About 17% of healthcare consumers were aware of one health system's estimator tool, but 0% had used it, according to new survey data. 

“This instability is putting in jeopardy our collective ability to meet the core objective of the No Surprises Act: to protect patients," ACR and others wrote recently. 

The FDA’s current draft guidance on the approval process for AI devices does not specify the type of validation the agency recommends manufacturers use. 

UPDATED: Private equity-backed groups such as Rad Partners have dominated IDR use, with "little evidence" rank-and-file radiologists are using the system, experts wrote in Health Affairs. 

Despite amassing a wait list of 10,000 individuals, the company has confronted “significant barriers due to restrictions on private imaging services in Ontario.” 

Beginning September 10, breast imaging facilities will be required to notify patients about the density of their breasts, among other regulatory changes. 

Dana H. Smetherman, MD, MBA, CEO of the ACR, discusses the reasons behind the worsening shortage of radiologists, along with possible solutions. 

Judge Ada Brown contends that the commission lacked evidence on why such a "sweeping ban" was necessary, rather than “targeting specific, harmful noncompetes.”